Latest filing published 14 Nov 2017 for HAEMONETICS CORP, €4,654.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -3.4%Entry US$25.50 · Close at T+365 US$24.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Susan Bartlett Foote: trading record in brief
All filings by Susan Bartlett Foote on record concern Haemonetics Corp. The record holds 67 filings, for trades running from 22 November 2005 to 10 November 2017.
Market trades split into 1 purchase (€42k) and 43 sales (€4.0M). The net balance comes to €4.0M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 12 share grants and 11 option exercises. Since January 2017: no purchases and 29 sales on the market.
The newest entry dates from 14 November 2017: an open-market sale of €4,650, in Haemonetics Corp. The last insider purchase was made public on 9 May 2006, 7,488 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Susan Bartlett Foote
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$54.200.1% of flowCommon StockSEC:0001127602-17-032090:17
- 200 shares@ US$54.210.3% of flowCommon StockSEC:0001127602-17-032090:18
- 2,500 shares@ US$54.223.4% of flowCommon StockSEC:0001127602-17-032090:19
- 500 shares@ US$54.230.7% of flowCommon StockSEC:0001127602-17-032090:20
- 100 shares@ US$54.400.1% of flowCommon StockSEC:0001127602-17-032090:26
- 100 shares@ US$54.450.1% of flowCommon StockSEC:0001127602-17-032090:27
- 6,573 shares@ US$45.457.5% of flowCommon StockSEC:0001127602-17-032090:0
- 290 shares@ US$54.060.4% of flowCommon StockSEC:0001127602-17-032090:1
- 200 shares@ US$54.070.3% of flowCommon StockSEC:0001127602-17-032090:2
- 400 shares@ US$54.090.5% of flowCommon StockSEC:0001127602-17-032090:3
- 510 shares@ US$54.100.7% of flowCommon StockSEC:0001127602-17-032090:4
- 1,200 shares@ US$54.111.6% of flowCommon StockSEC:0001127602-17-032090:5
- 600 shares@ US$54.120.8% of flowCommon StockSEC:0001127602-17-032090:6
- 600 shares@ US$54.130.8% of flowCommon StockSEC:0001127602-17-032090:7
- 200 shares@ US$54.140.3% of flowCommon StockSEC:0001127602-17-032090:8
- 573 shares@ US$54.150.8% of flowCommon StockSEC:0001127602-17-032090:9
- 100 shares@ US$54.160.1% of flowCommon StockSEC:0001127602-17-032090:10
- 1,900 shares@ US$54.172.6% of flowCommon StockSEC:0001127602-17-032090:11
- 10,353 shares@ US$35.509.2% of flowCommon StockSEC:0001127602-17-032090:12
- 1,039 shares@ US$54.171.4% of flowCommon StockSEC:0001127602-17-032090:14
- 1,061 shares@ US$54.181.4% of flowCommon StockSEC:0001127602-17-032090:15
- 600 shares@ US$54.190.8% of flowCommon StockSEC:0001127602-17-032090:16
- 400 shares@ US$54.240.5% of flowCommon StockSEC:0001127602-17-032090:21
- 2,953 shares@ US$54.254.0% of flowCommon StockSEC:0001127602-17-032090:22
- 100 shares@ US$54.260.1% of flowCommon StockSEC:0001127602-17-032090:23
25 of 60 declarations
